Login
Home / 6242.TWO : TWO
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Li Kang Biomedical Co., Ltd.

TWD 33.9 -$5.30 (-13.52%)
TWO · 16 Sep 2026 03:26 UTC
Previous Close
TWD 33.8
Day Range
TWD 33.8TWD 33.9
Year Range
TWD 33.6TWD 41.5
Market Cap
1.08B
AVG Volume
10.17K
Trailing/Forward PE
14.07/-
PEG ratio
-1.31
Dividend Yield
5.90%
Next Earnings Date
-
Primary Exchange
Taipei ExchangeTW
Revenue (TWD)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (TWD)
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (TWD)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (TWD)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (TWD)
-200M-150M-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (TWD)
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (TWD)
0100M200M300MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (TWD)
0200M400M600MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-4-3-2-10124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%1%2%3%4%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (TWD)
0123Jul 17Jun 18Jun 19Jun 20Sep 21Jul 22Jun 23Jun 24Jun 25Jun 26
Book Value Per Share (TWD)
01020304024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (TWD)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
1214161820med 15.66Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-30%-20%-10%0%10%med -3.11%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
1.822.22.42.6med 2.22Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
789101112med 8.93Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
12.51517.52022.5med 17.31Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
1.21.41.61.8med 1.51Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Li Kang Biomedical Co., Ltd.
6242.TWO
Stockpicker

Video analysis: 6242.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.